The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Frequency of TLE3 overexpression in breast carcinoma subtypes including a large cohort of triple-negative patients.
Gargi D. Basu
Employment or Leadership Position - Caris Life Sciences
Anatole Ghazalpour
Employment or Leadership Position - Caris Life Sciences
David Arguello
Employment or Leadership Position - Caris Life Sciences
Raheela Ashfaq
Employment or Leadership Position - Caris Life Sciences
Honoraria - Genentech
Zoran Gatalica
Employment or Leadership Position - Caris Life Sciences
Matthew Jerome McGinniss
Employment or Leadership Position - Caris Life Sciences
Richard Blevins
Employment or Leadership Position - Caris Life Sciences
Kathleen D Danenberg
Employment or Leadership Position - Caris Life Sciences